InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Foundation Fighting Blindness Retinal Degeneration Fund. Director active across 1 company, notably Opus Genetics, Inc.. Aggregated, 1 filings have been recorded. Regulator: SEC (Form 4). All data is accessible without signup.